| Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer | Apr 03, 2013 |
| FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla | Mar 05, 2013 |
| Dako Launches Advanced Staining Platform at Global Pathology Congress | Mar 04, 2013 |
| Dako Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer Diagnostics | Feb 15, 2013 |
| Dako to Collaborate with Pfizer on Companion Diagnostics | Feb 12, 2013 |
| Dako enters collaboration with Eli Lilly and Company | Jan 07, 2013 |
| Dako acquires important IP rights in connectivity | Dec 21, 2012 |
| Agilent Technologies Names Lars Holmkvist Diagnostics and Genomics Group President | Sep 12, 2012 |
| Agilent Technologies Completes Acquisition of Dako | Jun 21, 2012 |
| FDA Approves Dako’s HercepTest™ and HER2 FISH pharmDx™ Kit as Companion Diagnostics for Genentech’s New Cancer Drug Perjeta™ | Jun 11, 2012 |
| Van Andel Research Institute and Dako sign agreement to license cancer diagnostic tool | May 17, 2012 |
| Agilent to Acquire Dako for $2.2 Billion | May 17, 2012 |
| Dako enters into collaboration with Genentech on the FDA regulatory submissions of Dako’s HercepTest™ and HER2 FISH pharmDx™ as companion diagnostics for trastuzumab emtansine | May 01, 2012 |
| Dako Pathology Catalog 2012 | Mar 02, 2012 |
| Dako Enters into an Additional Collaboration with Amgen on Developing a Companion Diagnostic Test for an Investigational Cancer Therapy in Clinical Development | Feb 20, 2012 |
| World-class laboratories rely on Dako’s new Artisan Link Pro for Special Stains diagnostics | Feb 16, 2012 |
| Dako revolutionizes cancer diagnostics with superfast ISH technology | Feb 06, 2012 |
| Dako and Amgen to collaborate in development of a companion diagnostic for an Amgen investigational cancer therapy | Jan 10, 2012 |
| FDA approves Dako HER2 CISH pharmDx Kit | Dec 14, 2011 |
| Dako enters into collaboration with Genentech on the regulatory submissions of Dako’s HercepTest and HER2 FISH pharmD as companion diagnostics for pertuzumab | Dec 09, 2011 |
| Dako Enters New Collaboration with Bristol-Myers Squibb on Pharmacodiagnostics | Nov 09, 2011 |
| New pricing provides better value for Australia and New Zealand customers | Aug 09, 2011 |
| No time like the present | Jul 22, 2011 |
| Dako protects its intellectual property rights | May 11, 2011 |
| Dako wins Fisher HealthCare supplier award | Apr 15, 2011 |
| Dako A/S appoints new CFO | Apr 07, 2011 |
| Dako continues to improve revenue and operating profit | Mar 23, 2011 |
| Dako and Epitomics enter into strategic alliance | Mar 21, 2011 |
| This is what it feels like to have breast cancer | Mar 18, 2011 |
| Dako 2011 Catalog Available Now! | Mar 11, 2011 |
| Dako Spain receives Royal Danish Export Award | Dec 13, 2010 |
| New study reveals unexpected cross-reactivity of clinically validated HER2 antibody | Dec 11, 2010 |
| Dako brings BioPorto’s kidney injury test to the world market | Nov 24, 2010 |
| Dako makes companion diagnostics available to all types of pathology laboratories | Nov 08, 2010 |
| Dako and Quintiles form alliance to speed development of personalized medicine | Nov 01, 2010 |
| Dako: FDA Approval of Diagnostic Tests Provides Hope for Patients with Stomach Cancer | Oct 21, 2010 |
| Dako: New H&E Solution Delivers World Class Efficiency and Quality | Aug 31, 2010 |
| Philips and Dako join forces in Digital Pathology | Aug 02, 2010 |
| Customer Story from Hong Kong | Aug 01, 2010 |
| Dako and Omnyx Sign Agreement within Digital Pathology | Jun 21, 2010 |
| Dako achieves all-time high revenue and operating profit in 2009 | Mar 02, 2010 |
| AstraZeneca and Dako Sign Agreement | Jan 18, 2010 |
New Zealand